The COPPER-B Trial

Completed · Not applicable

Conditions studied: Cardiovascular Diseases, Peripheral Vascular Disease, Arterial Occlusive Diseases, Peripheral Arterial Disease, Critical Limb Ischemia

In brief

The purpose of the COPPER - B study is to assess the feasibility, safety, and initial efficacy of paclitaxel administration using the OPC for the prevention of restenosis in infrapopliteal de novo and restenotic lesions and occlusions using a novel catheter, the OPC.

Key facts

Study ID

NCT02395744

Run by

Horizons International Peripheral Group

People needed

11

Starts

2015-03-11

Expected to finish

2017-02-23

Last updated by the study team

2017-02-27

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Cardiology Associates — Fairhope, Alabama, United States
• Cardiovascular Institute of the South — Houma, Louisiana, United States
• Michigan Outpatient Vascular Institute — Dearborn, Michigan, United States
• Cardiovascular Associates of East Texas — Tyler, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.